NCCMH E-bulletin - Vol 8 Iss 1 (Dec 2009 / Jan 2010)

The NCCMH's e-bulletin contains Internet links to the latest mental health news, including clinical news, health and social care guidance, publications and policy. Read the latest news below or use the news archive to find news items from the past. Issues of our e-bulletin are published every two months.

To get the e-bulletin delivered by E-mail, click here. To unsubscribe, please send a message to admin@nccmh.org.uk with the subject heading 'Unsubscribe NCCMH E-bulletin'.

Audit Commission PbR data assurance framework consultation for 2010/11 onwards
Dec 09 / Jan 10 - the next issue of this bulletin will be published in early April
British Medical Association (BMA) Equality body issues mental health warning
Care Quality Commission (CQC) CQC urges improved preventative mental health services Guidance on meeting new essential standards of quality and safety The results of the CQCs latest Count me in census
Clinical Knowledge Summaries (PRODIGY) / SCHIN Dementia – draft topic
Cochrane Collaboration New reviews: Amisulpride versus other atypical antipsychotics for schizophrenia       Disulfiram for the treatment of cocaine dependence Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy       Quetiapine versus other atypical antipsychotics for schizophrenia       Risperidone versus placebo for schizophrenia       Shared decision making interventions for people with mental health conditions       Sports and games for post-traumatic stress disorder (PTSD)       Sulpiride augmentation for schizophrenia       Treadmill training for patients with Parkinson's disease       Zotepine versus other atypical antipsychotics for schizophreniaNew protocols: Antidepressants for agitation and psychosis in dementia       Behavioural/cognitive-behavioural group-based parenting interventions for children age 3-12 with early onset conduct problems       Duloxetine for Generalized Anxiety Disorder (GAD)      Felbamate as an add-on therapy for refractory epilepsy       Generic versus non-generic prescribing for epilepsy       Opioid agonist maintenance for opioid dependent patients in prison       Paliperidone palmitate for schizophrenia       Physical activity for improving cognition in older people with mild cognitive impairment      Physical health care monitoring for people with serious mental illness       Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents       Psychosocial interventions for retention in drug abuse treatment  Psychosocial treatments for opioid dependent adolescents       Social skills training for children with attention deficit hyperactivity disorder (ADHD)       Strategies for improving adherence to antiepileptic drug treatment in patients with epilepsy   Supported employment for adults with severe mental illness       Treatment for alcohol-related neuropathy New titles: Acute observation units for schizophrenia and other serious mental illness Anti-inflammatory interventions for focal epilepsy syndromes Baclofen for alcohol withdrawal  Behavioural therapies versus other psychological therapies for depression  Behavioural therapies versus treatment as usual for depression  Cognitive behavioural therapies versus other psychological therapies for depression  Cognitive behavioural therapies versus treatment as usual for depression  Cognitive Behavioural Therapy for Obsessive Compulsive Disorder in individuals with Autistic Spectrum Disorder  Cognitive behavioural therapy for obsessive compulsive disorder in individuals with autistic spectrum disorder  Crisis Planning Intervention for Schizophrenia Culturally sensitive psychosocial interventions for schizophrenia Eslicarbazepine acetate add-on for drug-resistant partial epilepsy Group Cognitive Behaviour Therapy for Schizophrenia Humanistic therapies versus other psychological therapies for depression  Humanistic therapies versus treatment as usual for depression  Inpatient versus outpatient care for anorexia nervosa, bulimia nervosa and eating disorders not otherwise specified Lithium for schizoaffective disorder Methylphenidate slow release for ADHD in adults Psychodynamic therapies versus other psychological therapies for depression  Psychodynamic therapies versus treatment as usual for depression  Psychotherapeutic treatments for cannabis abusing or dependent adolescents  Repetitive transcranial magnetic stimulation (rTMS) for panic disorder Screening instruments for posttraumatic stress disorder (PTSD) in survivors of traumatic experiences Third wave cognitive behavioural therapies versus other psychological therapies for depression  Third wave cognitive behavioural therapies versus treatment as usual for depression
Department of Health (DH) Adult autism strategy consultation: a summary of the submissions received in response to the online consultation Brief guide to Local Involvement Networks (LINks) for health and social care managers Guidance on the consumption of alcohol by children and young people. A report by the Chief Medical Officer Improving care and saving money: learning the lessons on prevention and early intervention for older people Keeping Children and Young People in Mind: The Government's full response to the independent review of CAMHS Mental health clinical costing standards 2009/2010 New Horizons: a shared vision for mental health New National Clinical Director for dementia New NHS Campaign Reveals Unseen Alcohol Damage Secretary of State introduces five year plan to reshape the NHS Strengthening national commissioning: a consultation Tackling health inequalities: 2006-08 policy and data update for the 2010 national target The second year of the Independent Mental Capacity Advocacy Service: 2008/2009 The standard NHS contracts for acute hospital, mental health, community and ambulance services and supporting guidance World class commissioning - December 2009 update
European Agency for the Evaluation of Medicinal Products (EMEA) New CHMP EPARs on: Olanzapine Glenmark Europe INN: olanzapine Olanzapine Glenmark INN: olanzapine Olazax Disperzi INN: olanzapine Olazax INN: olanzapine Rivastigmine 1A Pharma INN: rivastigmine Rivastigmine Hexal INN: rivastigmine Rivastigmine Sandoz INN: rivastigmine CHMP revised EPARs on: Abilify INN: aripiprazole Rev. 19 Azilect INN: rasagiline Rev. 7 Cymbalta INN: duloxetine Rev. 11 Duloxetine Boehringer Ingelheim INN: duloxetine Rev. 2 Invega INN: paliperidone Rev. 3 Lyrica INN: pregabalin Rev. 11 XeristarINN: duloxetine Rev. 11 Zalasta INN: olanzapine Rev. 5 Withdrawals: Otsuka Pharmaceutical Europe Ltd to withdraw its application of an extension of indication for the centrally authorised Abilify (aripiprazole) tablets, orodispersible tablets and oral solution Other: European CHMP concludes review of valproate for bipolar disorder. See also a separate question and answer document. Guideline on clinical investigation of medicinal products in the treatment of epileptic disorders Questions and answers on the refererral for Losec INN: omeprazole
Food and Drug Administration (FDA) Approvals: Atomoxetine hydrochloride (anda # 079019) Glenmark generics; tentative approval Donepezil hydrochloride (anda # 077975)  Mutual pharm;  approval Gabapentin (anda # 090705)  Invagen; pharms approval Levetiracetam (anda # 090261)  Mylan; approval Lyrica (nda # 022488)  Pfizer; approval Memantine (anda # 090073)  Wockhardt; tentative approval Memantine hydrochloride (anda # 090041)  Amneal pharms; tentative approval Memantine hydrochloride (anda # 090044)  Orchid hlthcare;  tentative approval Memantine hydrochloride (anda # 090051)  Lupin pharms; tentative approval Oxcarbazepine (anda # 090239) Cadista pharms; approval Pramipexole dihydrochloride (anda # 090781)  Pramipexole dihydrochloride; tentative approval Risperidone (anda # 078116)  Sandoz;  approval Zyprexa relprevv (nda # 022173)  Eli lilly co; approval Other: FDA concludes data insufficient to approve pregabalin (Lyrica) as monotherapy for generalised anxiety disorder FDA panel request stronger warnings about metabolic effects of aripiprazole (Abilify) in children to be included in license
Health Information Resources (formerly National Library for Health) Alzheimer's nutrient drink tested? Antidepressants and stroke Can mobile phones halt Alzheimer's? Eye scan could detect Alzheimer's? Skunk linked to psychosis Will pumping iron fight dementia?
Health Technology Assessment Published research: Are adverse effects incorporated in economic models? An initial review of current practice Development of a toolkit and glossary to aid in the adaptation of health technology assessment (HTA) reports for use in different contexts HTA report: are adverse effects incorporated into economic models? The clinical and cost effectiveness of testing for cytochrome P450 polymorphisms in patients treated with antipsychotics: a systematic review and economic evaluation News: Public involvement improves research says new report Treatment for young people with ADHD
InfoPOEMs Depression screening effective only with follow-up: USPSTF
IT Shared Services The Commissioning Friend for Mental Health Services
Kings Fund New publications: Getting the measure of quality NHS Workforce planning Windmill
Medicines and Healthcare products Regulatory Agency (MHRA) MHRA Drug Safety Update: New patient information for methylphenidate
Midlands Therapeutics Review & Advisory Committee (MTRAC) Duloxetine (GAD) Verdict/Summary [VS09\16] Agomelatine Verdict/Summary [VS09\17]
National Audit Office (NAO) Improving dementia services in England - an interim report
National electronic Library for Medicines (NeLM) Antiepileptic drugs do not raise suicide risk in bipolar patients? CBT effective for depressive illness in older people in primary care Clinical Review: Managing and preventing depression in adolescents Comment: Bapineuzumab for Alzheimer's disease Comment: composite outcomes in clinical trials Converting from brand to generic clozapine doesn't appear to have any major adverse effects Could angiotensin receptor blockers reduce incidence and progression of Alzheimer's disease? Dopamine agonist withdrawal syndrome in Parkinson's disease Editorial: How NICE decides what we should pay Findings from the Drug Treatment Outcomes Research Study Ginkgo biloba doesn't prevent cognitive decline in the elderly Mechanisms of disease review: Alzheimer's disease Meta-analysis: antidepressive drug efficacy rises with severity of depression SSRI may affect personality factors positively in depressive illness
National Institute for Health and Clinical Excellence (NICE) NICE commissioning guides covering service for the treatment and management of schizophrenia in adults
National Mental Health Development Unit (NMHDU) Invitation to tender for a contract to deliver a learning-network programme to support the mental health personal health budgets pilots New guide for mental health commissioners published Patient Opinion Launches Mental Health Service
National Patient Safety Agency (NPSA) Preventing suicide: a toolkit for mental health services
National Prescribing Centre (NPC) Guide (3rd edition) to good practice in the management of controlled drugs in primary care (England)
NHS Confederation NHS Confederation comments on UK's four health systems
NHS Evidence – mental health NHS Evidence - Quality and Productivity
NHS Networks World class services for people with long term conditions: information tool for commissioners Practice-based commissioning: budget guidance for 2010/11
Rethink Charity victory heralds new dawn for job applicants with mental health problems Government U-turn on jury service provokes urgent launch of charity campaign Mental health charity responds to Conservative health manifesto Mental health plans win backing and call for cash support MPs and health trusts urged to remove mental illness barriers from politics Parliamentary committee calls for mental health law to be repealed
Royal College of General Practitioners (RCGP) RCGP Releases 3rd Version of the Revalidation Guide for GPs
Royal College of Psychiatrists (RCPsych) Psychiatrists welcome call to end disqualification of MPs on grounds of mental illness Royal College of Psychiatrists’ President comments on mental health strategy launch Safe and Appropriate Care for Young People on Adult Wards
Royal Pharmaceutical Society of Great Britain (RPSGB) Society urges PCOS to improve commissioning on medicines
Sainsbury Centre for Mental Health (SCMH) Sainsbury Centre welcomes government commitment to improve mental health at work Sainsbury Centre welcomes government health strategy for children and young people in youth justice system Sainsbury Centre welcomes 'visionary' House of Commons report on justice reinvestment Whole government signs up to mental health and wellbeing
Scottish Intercollegiate Guidelines Network (SIGN) Non-pharmaceutical management of depression SIGN Guideline 113: Diagnosis and pharmacological management of Parkinson's disease
The next issue of our bulletin is due to be published in early April